REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction

PHASE2CompletedINTERVENTIONAL
Enrollment

223

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

July 31, 2009

Study Completion Date

January 31, 2011

Conditions
Acute ST Elevation Myocardial Infarction
Interventions
DRUG

Epoetin alfa

Randomized

Trial Locations (16)

10021

NY Presbyterian Hospital, New York

Weill Medical College, New York

11215

New York Methodist Hospital, Brooklyn

17033

Penn State Heart and Vascular Institute, Hershey

20010

Washington Hospital Center, Washington D.C.

23298

Virginia Commonwealth University Medical Center, Richmond

27103

Wake Forest University, Winston-Salem

27710

Duke University, Durham

30322

Emory University Hospital, Atlanta

33136

University of Miami, School of Medicine, Miami

37027

Nashville Cardiovascular Magnetic Resonance Institute, Brentwood

43210

Ohio State University Medical Center, Columbus

48202

Henry Ford Hospital, Detroit

55905

Mayo Clinic, Rochester, Rochester

48073-6769

William Beaumont Hospital, Royal Oak

10021-4872

Cornell University, New York

All Listed Sponsors
lead

National Institute on Aging (NIA)

NIH

NCT00378352 - REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction | Biotech Hunter | Biotech Hunter